Pathology & Oncology Research (2019) 25:817–818 https://doi.org/10.1007/s12253-018-0443-3 LETTER TO THE EDITOR JAK Pseudokinase Domain Variants Highlight nRTK VUSs Identified with Next-Generation Sequencing in Solid Tumor Patients 1,2 3 1 Matthew K. Stein & Lindsay K. Morris & Mike G. Martin Received: 21 November 2017 /Accepted: 30 May 2018 /Published online: 3 June 2018 Arányi Lajos Foundation 2018 Main Text undetermined significance (VUS) were included. All variants had >99% detection confidence based upon allele frequency Non-receptor tyrosine kinase (nRTK) pathways are aberrantly and amplicon coverage. In order to classify VUS, in silico activated in cancer, and mutations in nRTKs have potential analysis with PolyPhen-2 was utilized to predict pathogenicity therapeutic and prognostic importance. Consisting of 10 fam- . Any VUS predicted-damaging with in silico analysis we ilies, the 32 known human nRTKs each include a TKD made denote VUSp. VUSs were then classified as occurring within of N and C-terminal lobes necessary for catalytic activity, as or outside of the TKD; PSKD lesions were also detailed for well as varying regulatory regions including Src homology 2 JAK1–3. (SH2) and 3 (SH3), and in the case of the Janus kinases a 346 patients (79 breast, 110 colon and 157 non-small cell
Pathology & Oncology Research – Springer Journals
Published: Jun 3, 2018
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera